Radiation Dose to Patients from Radiopharmaceuticals

Annals of the ICRP

Volumn 18, Issue 1-4, 1987, Pages 1-29

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973202937     PISSN: 01466453     EISSN: None     Source Type: Journal    
DOI: 10.1016/0146-6453(87)90003-0     Document Type: Review

References (39)

1. Ahlgren, L. Ivarsson, S. Johansson, L. Mattsson, S. and Nosslin, B. (1985). Excretion of radionuclides in human breast milk after the administration of radiopharmaceuticals. J. Nucl. Med. 26, 1085-1090.
2. ARSAC (1984). Administration of Radioactive Substances Advisory Committee. Notes for Guidance on the Administration of Radioactive Substances to Persons for Purposes of Diagnosis, Treatment or Research, EN(84)5. Published by Dept of Health and Social Security, London.
3. Berman, M. (1977). Kinetic Models for Absorbed Dose Calculation, Medical Internal Radiation Committee (MIRD) Pamphlet No. 12. Available from Society of Nuclear Medicine, 475 Park Avenue South, New York, NY 10016, USA.
4. Cloutier, R. J. Watson, E. E. Rohrer, R. H. and Smith, E. M. (1973). Calculating the radiation dose to an organ. /. Nucl. Med. 14, 53-55.
5. Coakley, A. J. and Mountford, P. J. (1985). Nuclear medicine and the nursing mother. Br. Med. J. 291, 159-160.
6. Coffey, J. L. and Watson, E. E. (1979). Calculating doses from remaining body activity. A comparison of two methods. Med. Phys. 6, 307-308.
7. Garby, L. Löfveberg, S. and Nosslin, B. (1969). Radiation Doses from Radioactive Substances in Medical Use. Swedish National Institute of Radiation Protection, Stockholm (in Swedish).
8. Gelfand, M. J. Thomas, S. R. and Kereiakes, J. G. (1983). Absorbed radiation dose from routine imaging of the skeleton in children. Ann. Radiol 26, 421-423.
9. IAEA (1984). The Quality Control of Nuclear Medicine Instruments, Technical Document No. 317. International Atomic Energy Agency, Vienna, Austria.
10. ICRP (1971). Protection of the Patient in Radionuclide Investigations, ICRP Publication 17. Pergamon, Oxford.
11. ICRP (1973). Alkaline Earth Metabolism in Adult Man, ICRP Publication 20. Pergamon, Oxford.
12. ICRP (1977). Recommendations of the International Commission on Radiological Protection, ICRP Publication 26. Pergamon, Oxford.
13. ICRP (1978). Statement from the 1978 Stockholm Meeting of the ICRP, ICRP Publication 28. Pergamon, Oxford.
14. ICRP (1979). Limits for Intakes of Radionuclides by Workers, ICRP Publication 30: Part 1. Pergamon, Oxford.
15. ICRP (1980). Limits for Intakes of Radionuclides by Workers, ICRP Publication 30: Part 2. Pergamon, Oxford.
16. ICRP (1981). Limits for Intakes of Radionuclides by Workers, ICRP Publication 30: Part 3. Pergamon, Oxford.
17. ICRP (1987). Protection of the Patient in Nuclear Medicine, ICRP Publication 52. Pergamon, Oxford.
18. ICRU (1979). Methods of Assessment of Absorbed Dose in Clinical Use of Radionuclides, ICRU Report 32. International Commission on Radiation Units and Measurements, Bethesda, Maryland.
19. Johansson, L. Mattsson, S. and Carlsson, S. (1981a). Effective dose equivalent from long-lived radionuclide impurities in Tc-99m-pertechnetate. In: Third International Radiopharmaceutical Dosimetry Symposium (Proc. Conf. Oak Ridge, Tennessee, 1980), HHS Publication (FDA 81-8166), pp. 602-615. Department of Health and Human Services, Bureau of Radiological Health, Rockville, Maryland.
20. Johansson, L. Mattsson, S. and Nosslin, B. (1981b). Radiation Doses from Radioactive Substances in Medical Use. Swedish National Institute of Radiation Protection, Stockholm. (In Swedish with an English word list).
21. Kaul, A. Oeff, K. Roedler, H. D. and Vogelsang, T. (1973a). Radiopharmaceuticals-Biokinetic Data and Results of Radiation Dose Calculations. Informationsdienst fur Nuklearmedizin, Berlin.
22. Kaul, A. Oeff, K. Roedler, H. D. and Vogelsang, T. (1973b). Die Strahlenbelastung von Patienten bei der nuklearmedizinischen Anwendung offener radioaktiver Stoffe. Informationsdienst fur Nuklearmedizin, Berlin.
23. Kaul, A. Hinz, G. Kossel, F. Konig, K. Kragh, P. Nitschke, J. Roedler, H. D. and Schwarz, E. R. (1984). The Effective per Caput Dose Equivalent as a Measure of Medical Radiation Exposure of the Population-A Complement or an Alternative to the Genetically Significant Dose? ISH Report 52. Institut fur Strahlenhygiene des Bundesgesundheitsamtes, Neuherberg, Federal Republic of Germany.
24. Kaul, A. Krauss, O. and Petrausch, G. (1985). Strahlenexposition durch Tc-99m-Methylendiphosphonat-lokale Dosisverteilung in Wachstum szonen des kindlichen Skeletts und Organdosen. In: Medizinische Physik 1985. (Poretti, G. ed.). Deutsche Gesellschaft fur medizinische Physik, Bern, Switzerland.
25. Loevinger, R. and Berman, M. (1968). A schema for absorbed-dose calculations for biologically distributed radionuclides. Medical International Radiation Dose Committee (MIRD) Pamphlet No. 1. /. Nucl. Med 9, Suppl. 1,7-14.
26. NCRP (1982). Nuclear Medicine-Factors Influencing the Choice and Use of Radionuclides in Diagnosis and Therapy, NCRP Report No. 70. National Council on Radiation Protection and Measurements, Bethesda, Maryland.
27. NCRP (1985a). The Experimental Basis for Absorbed-Dose Calculations in Medical Uses of Radionuclides, NCRP Report No. 83. National Council on Radiation Protection and Measurements, Bethesda, Maryland.
28. NCRP (1985b). General Concepts for the Dosimetry of Internally Deposited Radionuclides, NCRP Report No. 84. National Council on Radiation Protection and Measurements, Bethesda, Maryland.
29. Roedler, H. D. (1981). Accuracy of internal dose calculations with special consideration of radiopharmaceutical biokinetics. In: Third International Radiopharmaceutical Dosimetry Symposium (Proc. Conf. Oak Ridge, Tennessee, 1980), HHS Publication (FDA 81-8166). Department of Health and Human Welfare, Bureau of Radiological Health, Rockville, Maryland.
30. Roedler, H. D. and Kaul, A. (1976). Dose to target organs from remaining body activity: Results of the formally exact and approximate solution. In: Radiopharmaceutical Dosimetry Symposium (Proc. Conf. Oak Ridge, Tennessee, April 1976), HEW Publication (FDA 76-8044), pp. 155-163. Department of Health, Education and Welfare, Bureau of Radiological Health, Maryland.
31. Roedler, H. D. Kaul, A. Berner, W. Koeppe, P. and Glaubitt, D. (1972). Development of an extended formalism for internal dose calculations and practical applications to several biologically distributed radioelements. In: Assessment of Radioactive Contamination in Man (Proc. Symp. Stockholm, 1971), pp. 515-541. International Atomic Energy Agency, Vienna, Austria.
32. Roedler, H. D. Kaul, A. and Hine, G. J. (1978). Internal Radiation Dose in Diagnostic Nuclear Medicine. Hoffman, Berlin.
33. Snyder, W. S. Ford, M. R. Warner, G. G. and Fisher, Jr, H. R. (1969). Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. Medical Internal Radiation Dose Committee (MIRD) Pamphlet No. 5. J. Nucl. Med. 10, Suppl. 3.
34. Snyder, W. S. Ford, M. R. Warner, G. G. and Watson, S. B. (1974). A Tabulation of Dose-equivalent per Microcuriedayfor Source and Target Organs of an Adult for Various Radionuclides, Report ORNL-5000. Oak Ridge National Laboratory, Tennessee; National Technical Information Service, Springfield, Virginia.
35. Snyder, W. S. Ford, M. R. Warner, G.G. and Watson, S.B. (1975). “S” Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs, Medical Internal Radiation Dose Committee (MIRD) Pamphlet No. 11. Available from Society of Nuclear Medicine, 475 Park Avenue South, New York, NY 10016, USA.
36. Snyder, W. S. Ford, M. R. and Warner, G. G. (1978). Estimates of Specific Absorbed Fractions for Photon Sources Uniformly Distributed in Various Organs of a Heterogeneous Phantom, Medical Internal Radiation Dose Committee (NM/MIRD) Pamphlet No. 5, revised. Available from Society of Nuclear Medicine, 475 Park Avenue South, New York, NY 10016, USA.
37. Winchell, H. S. Horst, W. D. Braum, L. et at. (1980). N-isopropyl (123I)p-iodoamphetamine: Single-pass brain uptake and washout; binding to brain synaptosomes; and localisation in the dog and monkey brain. J. Nucl. Med. 21, 947-952.
38. WHO (1982). Quality Assurance in Nuclear Medicine. World Health Organisation, Geneva.
39. WHO (1986). Review of Quality Control in Nuclear Medicine, bga-Schrifter 8/1986. (Cradduck, T. D. Busemann-Sokole, E. and Roedler, H. D. eds) MMV Verlag, Munich.